{"id":"https://openalex.org/W2979495166","doi":"https://doi.org/10.1182/blood.v114.22.2860.2860","title":"Ex Vivo Multiplexed Signal Pathway Inhibitor Treatment Reveals Differential Sensitivity of Myeloma and Non-Myeloma Bone Marrow Cell Populations.","display_name":"Ex Vivo Multiplexed Signal Pathway Inhibitor Treatment Reveals Differential Sensitivity of Myeloma and Non-Myeloma Bone Marrow Cell Populations.","publication_year":2009,"publication_date":"2009-11-20","ids":{"openalex":"https://openalex.org/W2979495166","doi":"https://doi.org/10.1182/blood.v114.22.2860.2860","mag":"2979495166"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v114.22.2860.2860","doi":"https://doi.org/10.1182/blood.v114.22.2860.2860","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v114.22.2860.2860","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081819701","display_name":"Virginia A. Espina","orcid":"https://orcid.org/0000-0001-5080-5972","observed_orcids":["https://orcid.org/0000-0001-5080-5972"]},"institutions":[{"id":"https://openalex.org/I162714631","display_name":"George Mason University","ror":"https://ror.org/02jqj7156","country_code":"US","type":"education","lineage":["https://openalex.org/I162714631"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Virginia Espina","raw_affiliation_strings":["Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA,","institution_ids":["https://openalex.org/I162714631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018769545","display_name":"Alessandra Romano","orcid":"https://orcid.org/0000-0002-6333-4433","observed_orcids":["https://orcid.org/0000-0002-6333-4433"]},"institutions":[{"id":"https://openalex.org/I162714631","display_name":"George Mason University","ror":"https://ror.org/02jqj7156","country_code":"US","type":"education","lineage":["https://openalex.org/I162714631"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Alessandra Romano","raw_affiliation_strings":["Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA,","institution_ids":["https://openalex.org/I162714631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112545898","display_name":"Amy VanMeter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I162714631","display_name":"George Mason University","ror":"https://ror.org/02jqj7156","country_code":"US","type":"education","lineage":["https://openalex.org/I162714631"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy VanMeter","raw_affiliation_strings":["Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA,","institution_ids":["https://openalex.org/I162714631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046191778","display_name":"Gregory Joshua Orloff","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gregory Orloff","raw_affiliation_strings":["Fairfax Northern Virginia Hematology Oncology, Fairfax, VA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fairfax Northern Virginia Hematology Oncology, Fairfax, VA, USA,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044613951","display_name":"Alexander I. Spira","orcid":"https://orcid.org/0000-0003-1303-0447","observed_orcids":["https://orcid.org/0000-0003-1303-0447"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexander I. Spira","raw_affiliation_strings":["Fairfax/Northern VA Hem. Onc., Fairfax, VA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fairfax/Northern VA Hem. Onc., Fairfax, VA, USA,","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Dipti Patel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Dipti Patel","raw_affiliation_strings":["Fairfax/Northern VA Hem. Onc., Fairfax, VA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fairfax/Northern VA Hem. Onc., Fairfax, VA, USA,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015187893","display_name":"Christopher James Walker","orcid":"https://orcid.org/0000-0002-1819-7388","observed_orcids":["https://orcid.org/0000-0002-1819-7388"]},"institutions":[{"id":"https://openalex.org/I1286329397","display_name":"United States Geological Survey","ror":"https://ror.org/035a68863","country_code":"US","type":"government","lineage":["https://openalex.org/I1286329397","https://openalex.org/I1335927249"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Walker","raw_affiliation_strings":["Walker & Associates, Reston, VA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Walker & Associates, Reston, VA, USA","institution_ids":["https://openalex.org/I1286329397"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115076571","display_name":"Emanuel F. Petricoin","orcid":"https://orcid.org/0000-0001-8787-5990","observed_orcids":["https://orcid.org/0000-0001-8787-5990"]},"institutions":[{"id":"https://openalex.org/I162714631","display_name":"George Mason University","ror":"https://ror.org/02jqj7156","country_code":"US","type":"education","lineage":["https://openalex.org/I162714631"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Emanuel F Petricoin","raw_affiliation_strings":["Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA,","institution_ids":["https://openalex.org/I162714631"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086886026","display_name":"Lance A. Liotta","orcid":"https://orcid.org/0000-0001-5155-7907","observed_orcids":["https://orcid.org/0000-0001-5155-7907"]},"institutions":[{"id":"https://openalex.org/I162714631","display_name":"George Mason University","ror":"https://ror.org/02jqj7156","country_code":"US","type":"education","lineage":["https://openalex.org/I162714631"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Lance A Liotta","raw_affiliation_strings":["Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA,","institution_ids":["https://openalex.org/I162714631"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5018769545","https://openalex.org/A5081819701","https://openalex.org/A5086886026","https://openalex.org/A5115076571"],"corresponding_institution_ids":["https://openalex.org/I162714631"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.44204723,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"114","issue":"22","first_page":"2860","last_page":"2860"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/bone-marrow-microenvironment","display_name":"bone marrow microenvironment","score":0.8859999775886536},{"id":"https://openalex.org/keywords/tyrosine-kinase-signaling","display_name":"tyrosine kinase signaling","score":0.8090000152587891},{"id":"https://openalex.org/keywords/protein-phosphorylation","display_name":"protein phosphorylation","score":0.6819999814033508},{"id":"https://openalex.org/keywords/reverse-phase-protein-microarrays","display_name":"reverse phase protein microarray","score":0.9390000104904175},{"id":"https://openalex.org/keywords/ex-vivo-drug-sensitivity","display_name":"ex vivo drug sensitivity","score":0.5600000023841858},{"id":"https://openalex.org/keywords/cd138-myeloma-cells","display_name":"CD138+ myeloma cells","score":0.7860000133514404},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.777999997138977},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.5820000171661377},{"id":"https://openalex.org/keywords/insulin-like-growth-factor-i","display_name":"insulin-like growth factor I","score":0.8389999866485596},{"id":"https://openalex.org/keywords/scf","display_name":"SCF","score":0.8700000047683716},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.7409999966621399},{"id":"https://openalex.org/keywords/off-target-effects","display_name":"off-target effects","score":0.6230000257492065}],"concepts":[{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.6458873748779297},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6310473680496216},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.5728067755699158},{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.5364499688148499},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49095419049263},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.4900275468826294},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.4875487685203552},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.4141128659248352},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.38689014315605164},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.36685752868652344},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.35920894145965576},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.18128260970115662},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v114.22.2860.2860","doi":"https://doi.org/10.1182/blood.v114.22.2860.2860","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v114.22.2860.2860","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.7900000214576721,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W96654567","https://openalex.org/W3039910284","https://openalex.org/W2979332446","https://openalex.org/W2562037434","https://openalex.org/W2980766927","https://openalex.org/W4366590381","https://openalex.org/W2979326559","https://openalex.org/W3016333719","https://openalex.org/W2030818104","https://openalex.org/W7135019619"],"abstract_inverted_index":{"Abstract":[0,1],"2860":[2],"Poster":[3],"Board":[4],"II-836":[5],"Multiple":[6],"Myeloma":[7],"(MM)":[8],"is":[9,27,73,111],"a":[10,54,112,192,210,243,332,519,532],"heterogeneous":[11],"disease,":[12],"and":[13,60,99,133,187,198,226,277,314,370,411,603],"despite":[14],"significant":[15],"advances":[16],"in":[17,57,264,284,331,337,368,405,467,491,508,538,545,576,585,589],"therapy":[18],"it":[19],"remains":[20],"incurable.":[21],"A":[22],"major":[23],"challenge":[24],"facing":[25],"clinicians":[26],"to":[28,65,75,178,230,289,307,360,379,407,425,438,487,614],"determine":[29],"which":[30,34,525,590],"new":[31,69],"agent":[32],"or":[33,86,171,396,445,555],"combinations":[35],"of":[36,45,71,89,103,123,136,145,150,160,194,213,248,275,302,317,413,478,503,535,593,612],"agents":[37,471,572],"will":[38],"prove":[39],"efficacious":[40],"for":[41,116,165,182,238,321,583],"individual":[42,265],"patients.":[43],"Interaction":[44],"MM":[46,341],"cells":[47,52,282,344,353,423,427,485,490],"with":[48,191,390,465,469,558],"bone":[49,152,244,266,280,325,350,493,595],"marrow":[50,153,175,245,267,281,326,351,494,596],"microenvironment":[51,352],"has":[53,386],"pathogenetic":[55],"role":[56],"the":[58,100,131,255,261,272,297,303,312,324,348,384,421,429,434,443,450,461,479,483,488,492,504,527,594],"disease":[59,97],"confers":[61],"tumor":[62,276,279],"cell":[63,222,364,372,380,551],"resistance":[64],"conventional":[66],"therapies.":[67],"The":[68,84,250],"generation":[70],"therapies":[72,510],"designed":[74],"target":[76,132,209,305,313,505,569],"signal":[77,91,118,146,256,591],"transduction":[78],"pathways,":[79],"particularly":[80],"tyrosine":[81,522],"kinase":[82,338,523],"signaling.":[83],"phosphorylation,":[85],"activation":[87],"state,":[88],"kinase-driven":[90],"networks":[92],"contains":[93],"important":[94],"information":[95,129,310],"concerning":[96],"pathogenesis":[98],"ongoing":[101],"state":[102,122],"kinase-associated":[104,124],"therapeutic":[105,125,565],"targets.":[106],"Reverse-phase":[107],"protein":[108,117,220,227],"microarray":[109],"(RPMA)":[110],"reproducible,":[113],"high-throughput":[114],"system":[115],"pathway":[119,147,257,339,366,506],"profiling.":[120],"Phosphorylation":[121],"targets":[126],"provides":[127],"direct":[128,309],"regarding":[130,311],"off-target":[134,315],"effects":[135,316,419,477],"treatment.":[137,318,548],"We":[138,294],"describe":[139],"herein":[140],"an":[141,501,515],"ex":[142,189,408,559,577],"vivo":[143,190,409,560,578,586],"study":[144],"inhibitor":[148,524],"treatments":[149],"fresh":[151],"aspirate":[154,246,268,327],"samples":[155,328],"from":[156,242,347,428],"patients":[157,389,402,436,462,540],"undergoing":[158],"standard":[159],"care":[161],"hematological":[162],"work":[163],"up":[164],"multiple":[166],"myeloma":[167,422],"at":[168],"any":[169,475],"stage":[170],"treatment":[172,233,263,394,410,481,557],"course.":[173],"Bone":[174],"aspirates":[176],"(n=37":[177],"date),":[179],"not":[180,473],"required":[181],"diagnosis,":[183],"were":[184,252,329,345,375],"immediately":[185],"subdivided":[186],"treated":[188,283,376],"panel":[193],"molecular":[195,497,520,605],"targeted":[196,498,521,606],"inhibitors":[197,499,561],"combinations,":[199],"and/or":[200,205,567],"exogenous":[201],"ligands":[202],"(SCF,":[203],"IGF-1),":[204],"cytokines":[206],"(IL-6),":[207],"that":[208,334,374,573],"wide":[211],"range":[212],"cellular":[214,597],"pathways":[215],"(e.g.":[216],"proteosome,":[217],"angiogenesis":[218],"related,":[219],"degradation,":[221],"proliferation/survival,":[223],"insulin":[224],"response,":[225],"translation).":[228],"Up":[229],"48":[231],"different":[232],"conditions":[234,288],"can":[235],"be":[236,581,600],"studied":[237,437],"each":[239],"patient":[240],"sample":[241],"volume":[247],"5.0mL.":[249],"objectives":[251],"a)":[253],"measure":[254],"perturbations":[258],"caused":[259],"by":[260],"inhibitor/ligand":[262],"samples,":[269],"b)":[270],"compare":[271],"relative":[273],"sensitivity":[274],"non":[278],"admixture":[285],"under":[286],"identical":[287],"identify":[290],"predictive/prognostic":[291],"protein-based":[292],"biomarkers.":[293],"specifically":[295],"measured":[296],"post-translational":[298],"modifications":[299],"(i.e.":[300],"phosphorylation)":[301],"drug":[304,414],"substrates":[306],"provide":[308],"After":[319],"incubation":[320],"4":[322],"hours":[323],"placed":[330],"preservative":[333],"suppresses":[335],"fluctuations":[336],"proteins.":[340],"CD138":[342],"positive":[343],"separated":[346],"non-CD138+":[349,371,489],"via":[354],"immunomagnetic":[355],"sorting.":[356,381],"RPMA":[357],"was":[358,544],"used":[359],"quantitatively":[361],"map":[362],"75":[363],"signaling":[365,452,552],"endpoints":[367],"CD138+":[369,484],"populations":[373,598],"simultaneously":[377],"prior":[378],"To":[382],"date":[383],"accrual":[385],"included":[387],"untreated":[388,435],"MGUS,":[391],"smoldering":[392],"myeloma,":[393],"nai\u0308ve,":[395],"advanced":[397],"stage,":[398],"pre-treated":[399,464],"myeloma.":[400],"Individual":[401],"differed":[403],"widely":[404],"response":[406,566],"combination":[412,468,509],"treatments.":[415],"Dexamethasone":[416],"showed":[417],"differential":[418,476],"on":[420,482],"compared":[424,486],"non-myeloma":[426],"same":[430],"patient.":[431],"For":[432],"all":[433,460,539],"date,":[439],"dexamethasone":[440,466,480],"significantly":[441],"suppressed":[442],"phosphoAKT":[444],"NF-KB":[446],"endpoints,":[447],"while":[448],"increasing":[449],"pro-apoptotic":[451],"proteins":[453],"such":[454,511],"as":[455,512],"cleaved":[456],"caspases.":[457],"In":[458],"contrast,":[459],"heavily":[463],"other":[470],"did":[472],"show":[474,574],"microenvironment.":[495],"Many":[496],"induced":[500,531],"up-regulation":[502,534],"even":[507],"Rapamycin":[513],"plus":[514],"IGF-1R":[516],"inhibitor.":[517],"Sorafinib,":[518],"blocks":[526],"MAPK":[528],"(Raf/Mek/ERK)":[529],"pathway,":[530],"compensatory":[533],"ERK":[536],"T202/Y204":[537],"except":[541],"one":[542],"who":[543],"remission":[546],"after":[547,556,604],"Multiplexed":[549],"phosphoprotein":[550],"analysis":[553],"before":[554,602],"may":[562,580],"predict":[563],"patient-specific":[564],"off":[568],"effects.":[570],"Selected":[571],"efficacy":[575],"studies":[579,588],"considered":[582],"further":[584],"clinical":[587],"profiling":[592],"could":[599],"performed":[601],"therapy.":[607],"Disclosures:":[608],"No":[609],"relevant":[610],"conflicts":[611],"interest":[613],"declare.":[615]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2019-10-18T00:00:00"}